Peer Review reports
From: Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer
| Original Submission | ||
|---|---|---|
| 14 Aug 2013 | Submitted | Original manuscript |
| 15 Aug 2013 | Author responded | Author comments - Jun Cao |
| Resubmission - Version 2 | ||
| 15 Aug 2013 | Submitted | Manuscript version 2 |
| 22 Dec 2013 | Reviewed | Reviewer Report - Claus Hanusch |
| 2 May 2014 | Reviewed | Reviewer Report - Sara Hurvitz |
| 15 Jun 2014 | Author responded | Author comments - Jun Cao |
| Resubmission - Version 3 | ||
| 15 Jun 2014 | Submitted | Manuscript version 3 |
| 23 Jul 2014 | Reviewed | Reviewer Report - Sara Hurvitz |
| 25 Sep 2014 | Author responded | Author comments - Jun Cao |
| Resubmission - Version 4 | ||
| 25 Sep 2014 | Submitted | Manuscript version 4 |
| Publishing | ||
| 27 Oct 2014 | Editorially accepted | |
| 7 Nov 2014 | Article published | 10.1186/1471-2407-14-820 |
You can find further information about peer review here.